Little Green Pharma (ASX:LGP) Land And Improvements: A$61.87 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Little Green Pharma Land And Improvements?

Little Green Pharma ASX:LGP -4.11% Land And Improvements is A$61.87 Mil as of Mar. 2026. The stock has 3 warning signs investors should review.

Little Green Pharma's land and improvements for the quarter that ended in Mar. 2026 was A$61.87 Mil.

Little Green Pharma's quarterly land and improvements declined from Mar. 2025 (A$62.73 Mil) to Sep. 2025 (A$0.00 Mil) but then increased from Sep. 2025 (A$0.00 Mil) to Mar. 2026 (A$61.87 Mil).

Little Green Pharma's annual land and improvements increased from Mar. 2024 (A$60.18 Mil) to Mar. 2025 (A$62.73 Mil) but then declined from Mar. 2025 (A$62.73 Mil) to Mar. 2026 (A$61.87 Mil).

Little Green Pharma Land And Improvements Historical Data

* Premium members only.

The historical data trend for Little Green Pharma's Land And Improvements can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Little Green Pharma Land And Improvements Chart

Little Green Pharma Annual Data
Trend Jun19 Jun20 Jun21 Mar23 Mar24 Mar25 Mar26
Land And Improvements
Get a 7-Day Free Trial 37.03 56.11 60.18 62.73 61.87

Little Green Pharma Semi-Annual Data
Jun19 Jun20 Dec20 Jun21 Dec21 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Land And Improvements Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only 60.18 0.00 62.73 0.00 61.87

Little Green Pharma Land And Improvements Calculation

Land is the surface or crust of the earth, which can be used to support structures, and may be used to grow crops, grass, shrubs, and trees. Land is characterized as having an unlimited life (indefinite). Land improvement is a long-term asset which indicates the cost of the constructed improvements to land, such as driveways, walkways, lighting, and parking lots.

Frequently Asked Questions Learn more about Land And Improvements →
What does a Land And Improvements of A$61.87 Mil mean?
Little Green Pharma (ASX:LGP) has a Land And Improvements of A$61.87 Mil as of Mar. 2026. Land and improvements records the total value of a company's land and improvements to it. View historical data on Little Green Pharma and its competitors.
Is Little Green Pharma's Land And Improvements too high?
Little Green Pharma's current Land And Improvements is A$61.87 Mil.
How does Little Green Pharma's Land And Improvements compare to ZTS?
Little Green Pharma's Land And Improvements of A$61.87 Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Land And Improvements for a Drug Manufacturers company?
A good Land And Improvements depends on the Drug Manufacturers industry context. However, Land And Improvements should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Land And Improvements mean?
A high Land And Improvements can signal that a stock is expensive relative to its fundamentals. Land and improvements records the total value of a company's land and improvements to it. View historical data on Little Green Pharma and its competitors. Little Green Pharma's current Land And Improvements is A$61.87 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Little Green Pharma stock overvalued right now?
Based on GuruFocus' analysis, Little Green Pharma (ASX:LGP) is currently considered Significantly Undervalued. The stock's GF Value™ is A$0.18, compared to a current price of A$0.07 — trading 61.1% below its estimated fair value. The current Land And Improvements is A$61.87 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Land And Improvements calculated?
Land And Improvements is calculated from a company's financial statements. For Little Green Pharma (ASX:LGP), the current Land And Improvements is A$61.87 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Little Green Pharma Business Description

Address 13A Bedbrook Place, Shenton Park, West Perth, Perth, WA, AUS, 6008
Little Green Pharma Ltd is engaged in the vertically integrated medicinal cannabis business. The business activities of the company include cultivation, production, research and development, manufacturing, and distribution of medicinal cannabis products. The company's two key types of products available at Little Green Pharma are oils (which are ingested) and flowers (which are usually inhaled through vaporizing). It offers LGP-branded medicinal cannabis oil products in the Australian and European markets. The Group is organized into two operating segments: Australia and Europe (cultivation, production and distribution of cannabis products to Australian and European customers).